Existing labs built for higher volumes of fewer drugs aren’t as serviceable when the equation flips from scale-up to scale-out. Which it is, quickly: In 2023, 38% of new drugs were personalized ...

There’s been no shortage of either in recent weeks. Plunging valuations across the biotech sector were thrust into the ...

mRNA vaccines are a prime example of collaboration in modern biotech ... According to eLabNext co-founder Wouter de Jong, biotech labs eager to be at the forefront of innovation are quick to ...

Recombinant DNA is one of the first stories in modern biotechnology history ... Follow the story of recombinant DNA on the next several pages from its conception in the lab to medical products on the ...